Citations

Mayo Clinic

Showing 10 of 108599 citations.

Leadership, Communication, and Negotiation Across a Diverse Workforce*
Clohisy, Denis R., Yaszemski, Michael J. , Lipman, Joanne

Journal of Bone and Joint Surgery | June 21, 2017 | Volume: 99 | Issue: 12 | Pages: e60

10.2106/jbjs.16.00792 | PMID 28632597 Get It

Abstract: The current workforce in the United States is rapidly changing and is increasingly inclusive of individuals from a broad range of ages, ethnicities, and cultural backgrounds. Engaging and leading a diverse workforce creates great opportunities for innovation and adaptation in our evolving medical economic and clinical care delivery environment. For optimal engagement of employees and partners, orthopaedic surgeons must develop the necessary skills for executing change inside complex organizations and across teams composed of a variety of providers and skilled workers. Important skills include leadership, effective communication, and negotiation within an ever-changing employee milieu. Understanding generalizable differences between age-based generations can increase the effectiveness of one’s strategies to execute change and increase organizational performance. One of the greatest impediments to effective communication and negotiations that all leaders face is unconscious bias. For leaders, even the tiniest unconscious biases have an outsized impact. Common domains that harbor unconscious bias include sex, race, and ethnicity. Addressing unconscious bias begins with developing awareness and then deploying various tactics that might include equity in compensation, promotion, and “being heard.” Effective negotiation skills also are essential to lead a diverse workforce and develop a successful organization. The most basic goal in any negotiation should be to establish a relationship (or deepen an existing relationship) while seeking an agreement that provides win-win opportunities for all parties. To effectively achieve a win-win scenario, leaders must recognize and address their tendency to interpret others’ behaviors, values, and beliefs through the lens of their own beliefs and experiences. Finally, and fortunately, there is a set of leader attributes that transcends the generational differences and diversity that is encountered in the workplace. These attributes include integrity, credibility, effective listening, having a vision of your destination, fairness, humility, and caring.
Infantile Spasms and Injuries of Prematurity: Short-Term Treatment-Based Response and Long-Term Outcomes
Wallace, Adam, Allen, Victoria M. , Park, Kristen , Knupp, Kelly G.

Journal of Child Neurology | June 21, 2017 | Volume: 32 | Issue: 10 | Pages: 861-866

10.1177/0883073817712587 | PMID 28635418 Get It

The association of infantile spasms and periventricular leukomalacia and/or intraventricular hemorrhage is well documented. Data regarding early treatment-based and long-term outcomes are limited. A retrospective chart review identified children with infantile spasms born prematurely (<37 weeks) with diagnoses of periventricular leukomalacia and/or intraventricular hemorrhage. Thirteen children were included. Median gestational age was 30 weeks and age of onset of infantile spasms was 8 months. Nine children had intraventricular hemorrhage, 10 had periventricular leukomalacia, and 6 children had both. Twelve of 13 children had resolution of spasms. In responders, the successful medication was adrenocorticotropic hormone (ACTH) in 7, topiramate in 3, and vigabatrin in 2. Follow-up after a median of 7.1 years found that all patients had developmental delay but only 1 had refractory epilepsy. Standard therapies (ACTH and vigabatrin) appeared to be more effective than other treatments. Developmental delay is common in children with periventricular leukomalacia / intraventricular hemorrhage and infantile spasms, but refractory epilepsy might be less frequent.
Flipped Classrooms in Graduate Medical Education: A National Survey of Residency Program Directors
Wittich, Christopher M. , Agrawal, Anoop , Wang, Amy T. , Halvorsen, Andrew J. , Mandrekar, Jayawant N. , Chaudhry, Saima , Dupras, Denise M. , Beckman, Thomas J. , Oxentenko, Amy S.

Academic Medicine | June 21, 2017 | Volume: 93 | Issue: 3 | Pages: 471-477

10.1097/acm.0000000000001776 | PMID 28640030 Get It

Purpose To begin to quantify and understand the use of the flipped classroom (FC)—a progressive, effective, curricular model—in internal medicine (IM) education in relation to residency program and program director (PD) characteristics. Method The authors conducted a survey that included the Flipped Classroom Perception Instrument (FCPI) in 2015 regarding programs’ use and PDs’ perceptions of the FC model. Results Among the 368 IM residency programs, PDs at 227 (61.7%) responded to the survey and 206 (56.0%) completed the FCPI. Regarding how often programs used the FC model, 34 of the 206 PDs (16.5%) reported “never”; 44 (21.4%) reported “very rarely”; another 44 (21.4%) reported “somewhat rarely”; 59 (28.6%) reported “sometimes”; 16 (7.8%) reported “somewhat often”; and 9 (4.4%) reported “very often.” The mean FCPI score (standard deviation [SD]) for the in-class application factor (4.11 [0.68]) was higher (i.e., more favorable) than for the preclass activity factor (3.94 [0.65]) ( P < .001). FC perceptions (mean [SD]) were higher among younger PDs (≤ 50 years, 4.12 [0.62]; > 50 years, 3.94 [0.61]; P = .04) and women compared with men (4.28 [0.56] vs. 3.91 [0.62]; P < .001). PDs with better perceptions of FCs had higher odds of using FCs (odds ratio, 4.768; P < .001). Conclusions Most IM programs use the FC model at least to some extent, and PDs prefer the interactive in-class components over the independent preclass activities. PDs who are women and younger perceived the model more favorably.
Trends in P Value, Confidence Interval, and Power Analysis Reporting in Health Professions Education Research Reports: A Systematic Appraisal
Abbott, Eduardo , Serrano, Valentina, Rethlefsen, Melissa L. , Pandian, T.K., Naik, Nimesh D. , Pankratz, V. Shane , Cook, David A. , Abbott, Eduardo F, West, Colin P.

Academic Medicine | June 21, 2017 | Volume: 93 | Issue: 2 | Pages: 314-323

10.1097/acm.0000000000001773 | PMID 28640032 Get It

Purpose To characterize reporting of P values, confidence intervals (CIs), and statistical power in health professions education research (HPER) through manual and computerized analysis of published research reports. Method The authors searched PubMed, Embase, and CINAHL in May 2016, for comparative research studies. For manual analysis of abstracts and main texts, they randomly sampled 250 HPER reports published in 1985, 1995, 2005, and 2015, and 100 biomedical research reports published in 1985 and 2015. Automated computerized analysis of abstracts included all HPER reports published 1970–2015. Results In the 2015 HPER sample, P values were reported in 69/100 abstracts and 94 main texts. CIs were reported in 6 abstracts and 22 main texts. Most P values (≥77%) were ≤.05. Across all years, 60/164 two-group HPER studies had ≥80% power to detect a between-group difference of 0.5 standard deviations. From 1985 to 2015, the proportion of HPER abstracts reporting a CI did not change significantly (odds ratio [OR] 2.87; 95% CI 1.04, 7.88) whereas that of main texts reporting a CI increased (OR 1.96; 95% CI 1.39, 2.78). Comparison with biomedical studies revealed similar reporting of P values, but more frequent use of CIs in biomedicine. Automated analysis of 56,440 HPER abstracts found 14,867 (26.3%) reporting a P value, 3,024 (5.4%) reporting a CI, and increased reporting of P values and CIs from 1970 to 2015. Conclusions P values are ubiquitous in HPER, CIs are rarely reported, and most studies are underpowered. Most reported P values would be considered statistically significant.
The Development of a Glucose Dehydrogenase 3D-Printed Glucose Sensor: A Proof-of-Concept Study
Adams, Anngela C. , Belle, Jeffrey T. La , La Belle, Jeffrey T, Malkoc, Aldin

Journal of Diabetes Science and Technology | June 21, 2017 | Volume: 12 | Issue: 1 | Pages: 176-182

10.1177/1932296817715272 | PMID 28633541 Get It

This work represents a preliminary proof-of-concept design and verification of a 3D-printed glucose biosensor. The proof of concept presented is the first example of glucose dehydrogenase sensor fabricated by a 3D-printer while maintaining similar features to current lab-industry standards. The sensor was verified to detect physiological glucose concentrations between 0 and 400 mg/dL with a linear coefficient as high as .97. This study showed that it was possible to use 3D-printed technology to create a biosensor sensitive to glucose detection. As availability and functionality of 3D-printers expands, this technology has the potential to be an option for diabetes management. This preliminary study shows that the 3D-printed sensor platform holds promise for sensitive glucose detection.
Effectiveness of intra-articular therapies in osteoarthritis: a literature review
Wehling, Peter , Evans, Christopher H. , Wehling, Jana, Maixner, William, Evans, Christopher

Therapeutic Advances in Musculoskeletal Disease | June 21, 2017 | Volume: 9 | Issue: 8 | Pages: 183-196

10.1177/1759720x17712695 | PMID 28835778 Get It

Osteoarthritis is a painful, chronic disease with widespread burden on patients, communities, health and social care systems. Conservative therapies, such as nonpharmacological interventions, systemic drug treatment and intra-articular therapies are used before resorting to surgery; nonetheless, disease control often remains inadequate. Recent advances in osteoarthritis management have aimed to provide greater variety of treatment options. Here, we summarize a targeted literature review evaluating efficacy and safety of intra-articular therapies for osteoarthritis. Injections of intra-articular therapies directly into the joint avoid conventional barriers to joint entry, increase bioavailability and lower systemic toxicity. Intra-articular corticosteroids and hyaluronic acid are established United States Food and Drug Administration (US FDA)/European Medicines Agency (EMA)-approved treatments; however, concerns exist regarding effect duration, safety, effectiveness across populations and heterogeneity. Newer therapies, such as autologous blood products and mesenchymal stem cells, are in development. Benefits of autologous blood products (e.g. platelet-rich plasma, autologous conditioned serum) include an expected improved safety profile and direct targeting of osteoarthritis-related pathophysiology. Autologous conditioned serum is cell-free and manufactured by a standardized process, whereas platelet-rich plasma composition and characteristics can vary. Currently, only limited efficacy comparisons between these biological treatments can be drawn; long-term clinical and safety studies are needed to increase the efficacy evidence base and earn consideration in treatment frameworks.
Telomere Length and Pancreatic Cancer Risk—Reply
Antwi, Samuel O. , Boardman, Lisa A., Petersen, Gloria M. , Boardman, Lisa A., Antwi, Samuel O

Cancer Epidemiology, Biomarkers & Prevention | June 21, 2017 | Volume: 26 | Issue: 7 | Pages: 1158-1159

10.1158/1055-9965.epi-17-0307 | PMID 28634187 Get It

Room to Grow—What is the Current Role of Neuromodulation in Pediatric Bowel-Bladder Dysfunction?
Zigelmann, Matthew J., Reinberg, Yuri

Journal of Urology | June 20, 2017 | Volume: 198 | Issue: 3 | Pages: 498-499

10.1016/j.juro.2017.06.064 | PMID 28641087 Get It

Characterising cis -regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues
Lykke‐Andersen, Søren , Zhu, Bin , Xiao, Wenming , Hoskins, Jason W. , Zhang, Xijun , Rost, Lauren M., Collins, Irene , Bunt, Martijn van de , Jia, Jinping , Song, Lei , Jermusyk, Ashley , Chung, Charles C., Zhou, Weiyin , Matters, Gail L. , Kurtz, Robert C. , Jensen, Torben Heick , Brown, Kevin M., Ongen, Halit , Bamlet, William R. , Murray, Bradley A., McCarthy, Mark I. , Chatterjee, Nilanjan , Wolpin, Brian M. , Petersen, Gloria M. , Shi, Jianxin , Ámundadóttir, Laufey T. , Amundadottir, Laufey , Zhang, Mingfeng , Jia, Jinping, Parikh, Hemang M. , Zhang, Tongwu , Yeager, Meredith , Chanock, Stephen Jacob , Smith, Jill Palmer , Olson, Sara H. , Bamlet, William R , McCarthy, Mark I , Hoskins, Jason W

Gut | June 20, 2017 | Volume: 67 | Issue: 3 | Pages: 521-533

10.1136/gutjnl-2016-313146 | PMID 28634199 Get It

Objective To elucidate the genetic architecture of gene expression in pancreatic tissues. Design We performed expression quantitative trait locus (eQTL) analysis in histologically normal pancreatic tissue samples (n=95) using RNA sequencing and the corresponding 1000 genomes imputed germline genotypes. Data from pancreatic tumour-derived tissue samples (n=115) from The Cancer Genome Atlas were included for comparison. Results We identified 38 615 cis -eQTLs (in 484 genes) in histologically normal tissues and 39 713 cis -eQTL (in 237 genes) in tumour-derived tissues (false discovery rate <0.1), with the strongest effects seen near transcriptional start sites. Approximately 23% and 42% of genes with significant cis -eQTLs appeared to be specific for tumour-derived and normal-derived tissues, respectively. Significant enrichment of cis -eQTL variants was noted in non-coding regulatory regions, in particular for pancreatic tissues (1.53-fold to 3.12-fold, p≤0.0001), indicating tissue-specific functional relevance. A common pancreatic cancer risk locus on 9q34.2 (rs687289) was associated with ABO expression in histologically normal (p=5.8×10 −8 ) and tumour-derived (p=8.3×10 −5 ) tissues. The high linkage disequilibrium between this variant and the O blood group generating deletion variant in ABO (exon 6) suggested that nonsense-mediated decay (NMD) of the ‘O’ mRNA might explain this finding. However, knockdown of crucial NMD regulators did not influence decay of the ABO ‘O’ mRNA, indicating that a gene regulatory element influenced by pancreatic cancer risk alleles may underlie the eQTL. Conclusions We have identified cis -eQTLs representing potential functional regulatory variants in the pancreas and generated a rich data set for further studies on gene expression and its regulation in pancreatic tissues.
Clinical outcomes of HLA‐DPB1 mismatches in 10/10 HLA‐matched unrelated donor‐recipient pairs undergoing allogeneic stem cell transplant
Moyer, Ann M. , Hashmi, Shahrukh K. , Kroning, Cynthia M., Kremers, Walter K. , Goey, Steven R. De, Patnaik, Mrinal M. , Litzow, Mark R. , Gastineau, Dennis A. , Jacob, Eapen K., Kreuter, Justin D. , Wakefield, Laurie L., De Goey, Steven R, Hogan, William J. , Gandhi, Manish J. , Kremers, Walter K

European Journal of Haematology | June 20, 2017 | Volume: 99 | Issue: 3 | Pages: 275-282

10.1111/ejh.12916 | PMID 28632323 Get It

AbstractObjectiveHLA‐DPB1 matching may impact allogeneic hematopoietic stem cell transplantation (ASCT) outcomes; however, this locus is not in linkage disequilibrium with the remainder of the HLA genes. After classifying HLA‐DPB1 mismatches based on T‐cell epitope, avoiding non‐permissive mismatches may impact survival. We tested this hypothesis at a single academic institution.MethodsRetrospective HLA‐DPB1 genotyping was performed on 153 adult patients who underwent ASCT and unrelated donors matched for HLA‐A, B, C, DRB1, and DQB1 loci (10/10). Using the ImMunoGeneTics/HLA T‐cell epitope matching algorithm, mismatch status was classified as permissive or non‐permissive.ResultsOf 153 donor‐recipient pairs, 22 (14.4%) were HLA‐DPB1 matches, 64 (42.8%) permissive mismatches, and 67 (43.8%) non‐permissive mismatches. DPB1 mismatch increased risk of chronic graft‐versus‐host disease (cGVHD; RR 2.89 [1.19‐9.53], P=.016) compared with DPB1‐matched transplants, but there were no differences in overall mortality, risk of relapse, or acute GVHD (aGVHD). Combining matches and permissive mismatches and comparing to non‐permissive mismatches, there was no significant difference in overall survival or relapse; however, patients receiving non‐permissive mismatched transplants experienced greater risk of aGVHD overall and severe aGVHD (RR 1.66 [1.13‐2.44], P=.010 and RR 1.97 [1.10‐3.59], P=.024, respectively).ConclusionIn this single‐center study, HLA‐DPB1 matching influenced outcomes of patients undergoing ASCT for hematologic malignancy.